New Jersey Senate Bill S1359

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

Impact

If enacted, S1359 would amend existing laws relating to health insurance coverage, specifically those established by P.L.1995, c.316 and P.L.1995, c.328. The bill requires the Department of Health to specify regulations regarding lead screening, including necessary intervals and methods for such screenings. Furthermore, it mandates health care providers, including physicians and licensed facilities that serve children, to conduct lead screenings for all patients under the specified age, thus broadening the scope of preventive health care services aligned with federal guidelines.

Summary

Senate Bill 1359 aims to extend health insurance coverage for lead screenings to children aged 16 years and younger. Currently, health insurance companies in New Jersey are only mandated to cover such screenings for those under the age of six. This expansion represents a significant recognition of the risks associated with lead poisoning, particularly in children, who are especially vulnerable to its harmful effects. The bill seeks to reduce lead exposure, which is known to stunt development even at low levels of exposure.

Contention

While the bill aims to enhance child health and safety by ensuring comprehensive lead screenings, it may face debate regarding the implications for health insurance costs and coverage. Critics may argue that expanding mandates on health insurance companies could result in higher premiums or restricted coverage options for families. Proponents, however, will likely counter that the long-term health benefits of early lead detection and intervention will outweigh the initial costs associated with broader insurance coverage.